Amaryl P 15 mg/2 mg Tablet

USDailyMed:Pioglitazone AU:B3 A10BG03(WHO) AU:S4(Prescription only)UK:POM(Prescription only)US:℞-onlyEU:Rx-onlyIn general: ℞ (Prescription only) (RS)-5-(4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl)thiazolidine-2,4-dione 111025-46-8Y 4829 2694 DB01132Y 4663Y X4OV71U42S D08378Yas HCl:D00945Y CHEBI:8228Y ChEMBL595Y DTXSID3037129 Interactive image O=C1NC(=O)SC1Cc3ccc(OCCc2ncc(cc2)CC)cc3 InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)YKey:HYAFETHFCAUJAY-UHFFFAOYSA-NY Pioglitazone, sold under the brand nameActosamong others, is ananti-diabetic medicationused to treattype 2 diabetes.It may be used withmetformin, asulfonylurea, orinsulin.Use is recommended together with exercise and diet.It is not recommended intype 1 diabetes.It is takenby mouth. Common side effects include headaches, muscle pains, inflammation of the throat, and swelling.Serious side effects may includebladder cancer,low blood sugar,heart failure, andosteoporosis.Use is not recommended inpregnancyorbreastfeeding.It is in thethiazolidinedione(TZD) class and works by improving sensitivity of tissues to insulin. Pioglitazone was patented in 1985, and came into medical use in 1999.It is available as ageneric medication.In 2023, it was the 133rd most commonly prescribed medication in the United States, with more than 4million prescriptions.It was withdrawn in France and Germany in 2011.